BKD
Brookdale Senior Living, Inc.
SERVICES-NURSING & PERSONAL CARE FACILITIES
Brookdale Senior Living (BKD) Stock: Buy, Sell, or Hold?
$9.09
-0.29 (-3.14%)
▼
5d:
-18.81%
30d:
-10.23%
90d:
-27.61%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (52%)
Quality Score
39/100
Position
OVERSOLD
30-Day Fair Range
$9.69 – $10.70
Position: OVERSOLD
Forward P/E & Valuation
68.8x
CHEAP
vs 129.7x historical avg
Wall Street Target
$17.17
+83.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.79 / $11.45
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: BKD is down 18.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When BKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BKD is currently trading at $9.09, which is considered oversold relative to its 30-day fair value range of $9.69 to $10.70. From a valuation perspective, the stock is trading at a discount (Forward PE: 68.8) compared to its historical average (129.7). Remarkably, the market is currently pricing in an annual earnings decline of 19.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BKD is in a strong downtrend. Immediate support is located at $8.79, while resistance sits at $11.45. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: BKD scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.17 (+83.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BKD is in a strong downtrend. Immediate support is located at $8.79, while resistance sits at $11.45. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: BKD scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.17 (+83.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.69 -
$10.70
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.4%
Trading Range & Key Levels
30-Day Trading Range
$9.69 -
$10.70
Current vs Trading Range
OVERSOLD
Support Level
$8.79
Resistance Level
$11.45
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 83.0% below Wall St target ($17.17)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
68.82
Wall Street Target
$17.17
(+83.0%)
Revenue Growth (YoY)
-9.0%
Profit Margin
-1.3%
Valuation Discount vs History
-19.0% cheaper
PE vs Historical
68.8 vs 129.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.0%
(market-implied from PE analysis)
1-Year Target
$8.44
(-10%)
2-Year Target
$7.60
(-19%)
3-Year Target
$6.84
(-27%)
3-Yr Target (if PE normalizes)
(PE: 69→130)
$12.89
(+37%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 68.8 to 129.7
Stabilization Target:
$17.68
(+88.5%)
PE Expansion Potential:
+88.5%
Share BKD Analysis
Share this live BKD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BKD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 29, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message predicts a potential 20% price increase for $BKD in the near future, with no recent news articles available.
Key Retail Themes:
Price prediction
Trader sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:12 AM ET
Data refreshes hourly during market hours. Next update: 11:12 AM
Data refreshes hourly during market hours. Next update: 11:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BKD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 47 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 39 SELL |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 34 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BKD Research Pages
